Tower Research Capital LLC (TRC) - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,987
+16.8%
16,520
+211.7%
0.00%0.0%
Q2 2023$33,390
+278150.0%
5,300
+152.5%
0.00%
Q1 2023$12
-63.6%
2,099
-35.2%
0.00%
-100.0%
Q4 2022$33
-100.0%
3,241
-64.0%
0.00%
-50.0%
Q3 2022$151,000
+77.6%
9,010
+48.7%
0.00%0.0%
Q2 2022$85,000
+1316.7%
6,059
+1453.6%
0.00%
Q1 2022$6,000
-77.8%
390
-69.3%
0.00%
Q4 2021$27,000
+285.7%
1,271
+185.0%
0.00%
Q3 2021$7,000
-83.3%
446
-79.1%
0.00%
-100.0%
Q2 2021$42,000
+250.0%
2,129
+434.9%
0.00%
Q1 2021$12,0003980.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders